Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 4, Avril 2002
Page(s) 422 - 424
Section Le Magazine : Derniére Heure
DOI https://doi.org/10.1051/medsci/2002184422
Publié en ligne 15 avril 2002
  1. Krammer P. CD95’s deadly mission in the immune system. Nature 2000; 407 : 789–95.
  2. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of theFas ligand in the development of hepatitis. Nat Med 1997; 3 : 409–13.
  3. Janin A, Deschaumes C, Daneshpouy M, et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood 2002; 99 : 2940–7.
  4. D’Souza SD, Bonetti B, Balasingam V, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996; 184 : 2361–70.
  5. Su X, Hu Q, Kristan JM, et al. Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 2000; 164 : 2523–32.
  6. Ameisen JC. Apoptosis subversion: HIV-Nef provides both armor and sword. Nat Med 2001; 7 : 1181–2.
  7. Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000; 106 : 25–35.
  8. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282 : 490–3.
  9. Zeytun A, Nagarkatti M, Nagarkatti PS. Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas+ organs. Blood 2000; 95 : 2111–7.
  10. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effects of the anti-Fas antibody in mice. Nature 1993; 364 : 806–9.
  11. Lacronique V, Mignon A, Fabre M, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996;2 : 80–6.
  12. Huang DCS, Hahne M, Schroeter M, et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-XL. Proc Natl Acad Sci USA 1999; 96 : 14871–6.
  13. Kaplan H, Leibole M, Tezel T, Ferguson T. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med 1999; 5 : 292–7.
  14. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumu S, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186 : 1831–41.
  15. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293 : 293–7.
  16. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative caspase 8-independent cell death pathway using kinase RIP as effector molecule. Nat Immunol 2000; 1 : 489–95.
  17. Kerbel R. A cancer therapy resistant to resistance. Nature 1997; 390 : 335–6.
  18. Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000; 6 : 920–3.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.